Search Results - "Vuorinen, Sofia I."

Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling by Pham, Son H., Vuorinen, Sofia I., Arif, KM Taufiqul, Griffiths, Lyn R., Okolicsanyi, Rachel K., Haupt, Larisa M.

“…Despite the use of the highly specific anti-HER2 receptor (trastuzumab) therapy, HER2-positive breast cancers account for 20–30% of all breast cancer…”
Get full text

SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk by Vuorinen, Sofia I., Okolicsanyi, Rachel K., Gyimesi, Martina, Meyjes-Brown, Jacob, Saini, Deepa, Pham, Son H., Griffiths, Lyn R., Haupt, Larisa M.

“…In Australia, 13% of women are diagnosed with breast cancer (BC) in their lifetime with approximately 20,000 women diagnosed with the disease in 2021. BC is…”
Get full text